RXO Analyst Ratings
Oppenheimer Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $31
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
Barclays Sticks to Its Buy Rating for RXO, Inc. (RXO)
Jefferies Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $31
RXO, Inc. (RXO) Gets a Buy From Jefferies
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $30
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Raises Target Price to $20
RXO Analyst Ratings
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $31 to $32
Benchmark Co. Maintains RXO Inc(RXO.US) With Hold Rating
Jefferies Maintains RXO Inc(RXO.US) With Buy Rating, Cuts Target Price to $31
RXO Analyst Ratings
RXO, Inc. (RXO) Receives a Buy From Barclays
RXO Price Target Raised to $31.00/Share From $22.00 by UBS
RXO Analyst Ratings
Oppenheimer Adjusts RXO Price Target to $31 From $22, Maintains Outperform Rating
BofA Securities Adjusts Price Target on RXO to $32 From $22, Maintains Neutral Rating
Barclays Raises Price Target on RXO to $30 From $24, Maintains Overweight Rating